Madeleine Farman

Madeleine Farman

Madeleine Farman is the editor of PEI Group’s Secondaries Investor title based in London. Prior to joining PEI, she had covered private equity, private capital and advisers associated with the industry for other newsrooms and publications since 2016. Originally from New Zealand, Madeleine began her career in radio in Auckland.

News & Analysis

What do LPs think about funds closing below target?

LPs consider a vast number of metrics, including transparency, exposure and co-investment opportunities, before determining whether a fundraise was successful.

6 min read · 18 May 2023

News & Analysis

Demand from APAC managers for secondaries on the up

Supply from managers looking to the secondaries market to hold onto assets for longer periods continues to grow.

5 min read · 17 May 2023

Editor's View

Why missing your target is a nuanced affair in the eyes of some LPs

There are subtleties when it comes to how investors treat funds closing wide of the mark.

3 min read · 11 May 2023

News & Analysis

GPs face the music: The new reality of a 'failed' fundraise

Multiple managers have either closed or expect to close their latest private equity flagships below target – something unthinkable a few years ago.

7 min read · 10 May 2023

News & Analysis

CD&R set to exceed $20bn target for latest flagship

Clayton, Dubilier & Rice Fund XII, which launched last year, has a hard-cap of $23bn.

2 min read · 18 April 2023

News & Analysis

Inflexion sells GP stake to Hunter Point in bid to deepen Europe strategy

Hunter Point’s investment closely follows its stake purchase in consumer giant L Catterton last month.

2 min read · 06 April 2023

Managers

Industry Ventures targets $1bn for latest flagship VC secondaries fund

The VC secondaries specialist reached the $850m hard-cap for its predecessor, which held its final close in 2021.

2 min read · 04 April 2023

ArchiMed hits 300x return for debut fund with Polyplus exit

ArchiMed and Warburg Pincus have agreed to sell the France-headquartered business to life science group Sartorius for approximately €‎2.4bn.

2 min read · 04 April 2023

Deals

ArchiMed scores 300x return for debut fund with Polyplus exit

ArchiMed and Warburg Pincus have agreed to sell the France-headquartered business to life science group Sartorius for approximately €‎2.4bn.

2 min read · 04 April 2023

Featured

Tender offers: An industry staple

Tender offers plus staples can be a powerful tool to provide liquidity to cash-strapped LPs.

5 min read · 03 April 2023

Showing 141 to 150 of 210 results
1…1416…21